Investment – Page 19
-
FeaturesIPE Quest Expectations Indicator - March 2021
Vaccination figures are rising steadily, but are still at a relatively low level. The US and UK, both important vaccine producers, lead the field with the EU and Japan lagging. As the speed of vaccination has increased, supplies have become a problem, except in the UK. This has caused bad feelings in the EU to the point where a trade war was threatened. New vaccines are in the regulatory pipeline but market shares have largely already been divided in the developed countries. The discovery of new COVID-19 mutations and their resistance to vaccines are an additional risk.
-
FeaturesBriefing: Active ways to prosper in EMs
On the battlefield on which active managers fought their passive enemies for investors’ custom, there was one patch of higher ground that seemed easier to defend – emerging market equities.
-
FeaturesBriefing: The sum of all fears
Three years on from the onset of MiFID II, market participants, governments and regulators are assessing its outcomes and considering adjustments.
-
FeaturesBriefing: Tide turning for ESG fixed-income
The supply of ESG-aligned bonds is increasingly underpinned by regulatory pressures and client demand for products targeting non-financial objectives. As the investable universe grows, so the number of funds and assets will increasingly find their way towards fixed-income ESG solutions. However, to strike the right balance between financial and non-financial returns investors should look for ESG-authentic leaders with good risk-return capabilities
-
FeaturesStrategically Speaking: Mondrian Investment Partners
Clive Gillmore is a rarity nowadays among asset management CEOs in that he is keen to discuss what he sees as the difficult moral choices embodied in ESG investment
-
FeaturesFixed Income, Rates, Currencies: Same again in 2021?
The relief from the farewells to 2020, and welcoming a Brexit trade deal, has waned in the face of rising COVID-19 infection rates. There have also been further lockdowns across swathes of Northern Europe as well as in Japan, Thailand, and South Africa to name a few. The vaccine-generated light at the end of the tunnel which appeared last year, seems rather distant, and possibly dimmer too.
-
FeaturesAhead of the curve: Has the period of painless diversification ended?
With interest rates falling to historical lows the reality of a new financial landscape is confronting investors. It is one where the typical relationships between assets has come into question. In addition, basic ideas around diversification and portfolio construction no longer seem to match with the available investment opportunities.
-
-
-
FeaturesIPE Quest Expectations Indicator - February 2021
Interest has shifted from contamination and mortality data to vaccination figures. In this field, the US and UK are doing well, while the EU and Japan are lagging. Political risk is perceived to have gone. Donald Trump’s tendency to self-destruct is creating opportunities for the Republican Party to heal while Democrats are preparing an economic support package.
-
FeaturesBriefing: Still a strong case for US stimulus
The next awaited US stimulus programme remains a mystery. Congress must agree on funding specifics, but the final composition of the Senate will be unknown until this month. Republicans and Democrats have been battling over spending priorities since COVID-19 struck last spring, with competing priorities.
-
FeaturesStrategically Speaking: Hendrik Bartel, TruValue Labs
What makes ESG data providers stand out? For TruValue Labs, the answer is to apply AI and machine learning to thousands of unstructured data sources to enhance ESG investment processes
-
FeaturesFixed Income, Rates, Currencies: A very different recovery
Amongst the remarkable happenings in 2020, from startling news of a pandemic to viable vaccine and beyond, has been the speed and scale of interventions from central banks and governments.
-
FeaturesAhead of the curve: Options trading as a portfolio diversifier: pilot or passenger?
Options can provide insurance against market volatility, but require detailed knowledge to ensure success
-
-
-
FeaturesIPE Quest Expectations Indicator - January 2021
US COVID-19 figures were rising rapidly at the time of writing. Western European figures were divided. Many showed a climbdown from the second wave but Germany, the UK and the Netherlands were faced with growing figures. Japan’s statistics were up, forming a third wave. In a few weeks, we will know how the deployed vaccines work in practice.
-
FeaturesBriefing: Feast or famine
With the end of the COVID-19 pandemic still out of sight, any forecast of the size of economic damage it will inflict has to be viewed with caution. Yet there seems to be a consensus that default rates on leveraged loans will stay elevated throughout 2021 and beyond.
-
FeaturesBriefing: An unfortunate lack of ambition
The second Capital Markets Union (CMU) Action Plan of the EU Commission lacks ambition. This at a time when the EU Commission wants to set an industrial policy for the EU to bolster competitiveness in key sectors. It also comes shortly before the UK’s departure from the EU. Yet a vision of what the EU wants to achieve, by when and how, is missing.
-
FeaturesStrategically Speaking: BlueBay Asset Management
Nowadays, it seems fair to ask asset managers whether they believe they can fulfil their clients’ needs while at the same time doing their bit to fight COVID-19.
